CJC-1295 vs Sermorelin
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of CJC-1295 and Sermorelin (also searched as Sermorelin vs CJC-1295) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
CJC-1295 centers on muscle, while Sermorelin leans toward muscle. On indexed research, CJC-1295 is ahead (CJC-1295: 4 studies, Preclinical; Sermorelin: 3, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •CJC-1295 is strongest for muscle; Sermorelin for muscle.
- •Evidence: CJC-1295 Preclinical (4 studies) vs Sermorelin Human evidence (3).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
GHRH Analog | Growth Hormone Releasing Hormone
CJC-1295 vs Sermorelin: side-by-side
| Metric | CJC-1295 | Sermorelin |
|---|---|---|
| Class | — | GH |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Preclinical | Human evidence |
| Studies indexed | 4 | 3 |
| Research level | — | Well Studied |
| Strongest effect | Muscle & body comp | Muscle & body comp |
| Healing & recovery | 2.0 | 3.0▲ |
| Muscle & body comp | 4.0▲ | 4.0▲ |
| Metabolic & appetite | 3.0▲ | 3.0▲ |
| Neuro & mood | 2.0▲ | 2.0▲ |
| Sleep & circadian | 3.0▲ | 2.0 |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 1.0 | 3.0▲ |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | CJC-1295 | Sermorelin |
|---|---|---|
| Mechanism | GHRH (1–29) analog, modified | GHRH (1–29) analog |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~30 min | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is CJC-1295?
GHRH analogue used in research contexts for GH/IGF-1 modulation, muscle and bone density, sleep, and recovery.
Full CJC-1295 profile, mechanism & studies →What is Sermorelin?
### Summary Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to produce and release endogenous growth hormone. It has been investigated for its potential therapeutic applications, particularly in the context of growth hormone deficiencies and other related conditions.
Full Sermorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Sermorelin | 3.0/5 effect signal |
| Muscle | Even | Both ~4.0/5 |
| Metabolic | Even | Both ~3.0/5 |
| Neuro | Even | Both ~2.0/5 |
| Sleep | CJC-1295 | 3.0/5 effect signal |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Sermorelin | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack CJC-1295 and Sermorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
CJC-1295 vs Sermorelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
CJC-1295 has 4 approved studies indexed (Preclinical), and Sermorelin has 3 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is CJC-1295 or Sermorelin better?
It depends on your goal. CJC-1295 is strongest for muscle; Sermorelin for muscle. CJC-1295 has more indexed studies (4). See the goal-by-goal breakdown above.
Is CJC-1295 or Sermorelin better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is CJC-1295 or Sermorelin better for muscle?
Both land close on the muscle & body-composition axis.
Which has more research, CJC-1295 or Sermorelin?
CJC-1295 has 4 approved studies indexed (Preclinical); Sermorelin has 3 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack CJC-1295 and Sermorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of CJC-1295 vs Sermorelin?
CJC-1295: no community-reported effects logged yet. Sermorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is CJC-1295 or Sermorelin FDA-approved?
CJC-1295 is a research-use compound and is not FDA-approved. Sermorelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Sermorelin better than CJC-1295?
For muscle, Sermorelin has the edge; for muscle, CJC-1295 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
CJC-1295 and Sermorelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.